
Medicine and Health
Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer's disease mouse model
X. Cen, Y. Chen, et al.
This groundbreaking study reveals the therapeutic potential of UMI-77, a drug that activates neuronal mitophagy, targeting MCL-1 as a receptor. Conducted by Xufeng Cen and colleagues, it shows promise for reversing Alzheimer’s disease symptoms through potent mitophagy activation. A game-changer in Alzheimer's treatment!
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.